Cargando…
CRISPR-Cas9 approach confirms Calcineurin-responsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata
Invasive fungal infections, which kill more than 1.6 million patients each year worldwide, are difficult to treat due to the limited number of antifungal drugs (azoles, echinocandins, and polyenes) and the emergence of antifungal resistance. The transcription factor Crz1, a key regulator of cellular...
Autores principales: | Ceballos-Garzon, Andres, Roman, Elvira, Pla, Jesús, Pagniez, Fabrice, Amado, Daniela, Alméciga-Díaz, Carlos J., Le Pape, Patrice, Parra-Giraldo, Claudia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932611/ https://www.ncbi.nlm.nih.gov/pubmed/35303047 http://dx.doi.org/10.1371/journal.pone.0265777 |
Ejemplares similares
-
Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata
por: Ceballos-Garzon, Andres, et al.
Publicado: (2021) -
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2018) -
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland
por: Coste, A. T., et al.
Publicado: (2020) -
P017 Echinocandin resistance mechanism in Candida tropicalis and Candida glabrata
por: Sharma, Dipti, et al.
Publicado: (2022) -
Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
por: Singh-Babak, Sheena D., et al.
Publicado: (2012)